Is Hyperhomocyst(e)inemia A Humoral Predictor of Coronary Heart Disease?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|17|2187-2197

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.17, 2005-07, pp. : 2187-2197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Homocyst(e)ine and Coronary Heart Disease: Pharmacoeconomic Support for Interventions to Lower Hyperhomocyst(e)inaemia

By Nallamothu B.K.  

PharmacoEconomics, Vol. 20, Iss. 7, 2002-01 ,pp. : 429-442

Adis International

Access to resources Recommend Favorite

Economical Aspects of High-Sensitivity C-Reactive Protein as Predictor of Coronary Heart Disease

By  

Heart Drug, Vol. 2, Iss. 2, 2002-06 ,pp. : 61-68

Karger

Access to resources Recommend Favorite

The future of coronary heart disease prevention

By Wald David S  

Clinical Medicine, Vol. 7, Iss. 4, 2007-08 ,pp. : 392-396

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

By Nieminen Tuomo   Käähöönen Mika   Viiri Leena E   Gröönroos Paula   Lehtimääki Terho  

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1475-1486

Future Medicine

Access to resources Recommend Favorite

ALLIANCE: atorvastatin advantageous in coronary heart disease

By  

Inpharma, Vol. 1, Iss. 1429, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite